Explore the complete record of transactions filed by Schwab Gisela, Président, Développement des Produits et Affaires Médicales. Insider active across 1 companies, notably Exelixis, INC.. Cumulatively, 6 reports have been recorded. The latest transaction was disclosed on 26 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Gisela Schwab is the President of Product Development and Medical Affairs at Exelixis, Inc. She is responsible for product development strategy and medical innovation. Gisela plays a key role in the strategic direction of Exelixis, a company specializing in biotechnology.